Norgine, Marketing Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine in high-risk neuroblastoma Published on 08/07/2025 at 18:05 | prnewswire.co.uk Norgine United Kingdom United States of America Germany Spain Switzerland Netherlands Italy France Belgium Australia Austria View original content:https://www.prnewswire.co.uk/news-releases/norgine-submits-marketing-authorisation-application-to-the-european-medicines-agency-for-eflornithine-difluoromethylornithine-dfmo-in-high-risk-neuroblastoma-302343047.html en | boerse | 67964814 |
